NFKB1 and cancer: Cancer-associated chronic inflammation may request the application of nonsteroidal-based anti-inflammatory drugs (NSAIDs), such as acetaminophen or sulindac, to suppress undesired NF-κB-promoted production of growth and metastatic factors.